Award
Definitive Contract #80NSSC26C0113
Definitive Contract for In-Situ Radioisotope Sterilization Technology Development
Buyer
National Aeronautics and Space Administration
Award Amount
$1,274,900.00
Ceiling
$1,274,900.00
Awarded
September 15, 2026
Period of Performance
Sep 15, 2026 – Sep 14, 2028
Identifier
80NSSC26C0113
NAICS
541715
This definitive contract was awarded to G21 Nucleonics Inc., a company specializing in advanced nuclear technologies, for the development of an innovative in-situ radioisotope sterilization solution aimed at planetary protection. The contract focuses on creating low-mass, low-complexity sterilization methods to prevent both backward and forward contamination in space exploration contexts. This significant contract supports the agency’s planetary protection efforts by enabling safer and more efficient sterilization technologies critical for maintaining planetary environments and scientific integrity. The scope encompasses research and development activities culminating in demonstration of the sterilization technology over a multi-year period. The award resulted from a competitive process aligned with SBIR Phase II objectives, emphasizing technology maturation. Performance under this contract will take place in Seattle, Washington, over an approximately two-year timeline, reflecting a commitment to advancing safe space exploration capabilities.
Description
SBIR PHASE II - IN-SITU RADIOISOTOPE STERILIZATION FOR BACKWARD AND FORWARD CONTAMINATION - ENABLING LOW-MASS, LOW-COMPLEXITY SOLUTIONS FOR PLANETARY PROTECTION